Michael S Wyzga's Net Worth
Estimate Recalculated Jun 3, 2025 09:02PM EST
Who is Michael S Wyzga
Michael S Wyzga has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Altus Pharmaceuticals Inc., EXACT SCIENCES CORP, Radius Health, Inc., Adagio Therapeutics, Inc., LogicBio Therapeutics, Inc., Akebia Therapeutics, Inc., X4 Pharmaceuticals, Inc, OncoMed Pharmaceuticals Inc, IDENIX PHARMACEUTICALS INC, and Mereo BioPharma Group plc.
SEC CIK
Michael S Wyzga's CIK is 0001201256
Past Insider Trading and Trends
2007 was Michael S Wyzga's most active year for acquiring shares with 7 total transactions. Michael S Wyzga's most active month to acquire stocks was the month of May. 2011 was Michael S Wyzga's most active year for disposing of shares, totalling 13 transactions. Michael S Wyzga's most active month to dispose stocks was the month of March. 2010 saw Michael S Wyzga paying a total of $2,202,480.00 for 57,750 shares, this is the most they've acquired in one year. In 2011 Michael S Wyzga cashed out on 2,097,475 shares for a total of $36,615,965.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
